Overall, these results indicate that, despite the prognostic significance of ACAP1 expression varied by tumor type, low ACAP1 expression was associated with poor clinical outcomes in the majority of tumor types, especially solid tumors. The gene discussed is ACAP1; the disease is neoplasm.